Post-earnings recap
Reported
Wed, Nov 3, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Charles River Laboratories reported an EPS of $2.70, exceeding expectations by 5.14%. However, the stock reacted negatively, dropping 10.22%. This decline may reflect investor concerns despite the earnings beat, as no revenue figures or management commentary were provided.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.70 | N/A | +5.14% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.